Bacillus anthracis
- 1 March 2003
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 56 (3) , 182-187
- https://doi.org/10.1136/jcp.56.3.182
Abstract
The events of 11 September 2001 and the subsequent anthrax outbreaks have shown that the West needs to be prepared for an increasing number of terrorist attacks, which may include the use of biological warfare. Bacillus anthracis has long been considered a potential biological warfare agent, and this review will discuss the history of its use as such. It will also cover the biology of this organism and the clinical features of the three disease forms that it can produce: cutaneous, gastrointestinal, and inhalation anthrax. In addition, treatment and vaccination strategies will be reviewed.Keywords
This publication has 49 references indexed in Scilit:
- Crystal structure of the anthrax lethal factorNature, 2001
- Anthrax: clinical features, pathogenesis, and potential biological warfare threat.2000
- Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaquesVaccine, 1998
- PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: The presence of multiple Bacillus anthracis strains in different victimsProceedings of the National Academy of Sciences, 1998
- Anthrax Pathogenesis and Host ResponsePublished by Springer Nature ,1998
- The Sverdlovsk Anthrax Outbreak of 1979Science, 1994
- Evaluation of Serologic Tests for Diagnosis of Anthrax after an Outbreak of Cutaneous Anthrax in ParaguayThe Journal of Infectious Diseases, 1989
- Survival of a patient with intestinal anthraxThe American Journal of Medicine, 1977
- VALUE OF FIELD DATA FOR EXTRAPOLATION IN ANTHRAX1967
- HUMAN INHALATION ANTHRAX - A REPORT OF 3 FATAL CASES1960